Caitlin Whyte (Host): Welcome to Wake Med Voices.
I'm your host, Caitlin White.
And with me is Dr.
Chad Greer, a non-operative sports medicine physician at Wake Orthopedics.
Today we're diving into a topic that's changing the way we treat
bone, joint and soft tissue injuries, regenerative medicine
from platelet rich plasma to cell-based therapies.
These techniques aim to tap into the body's natural healing power,
often helping patient's recover faster, delay surgery, or get
back to the activities they love.
Gru.
To start us off today, can you tell us what is regenerative medicine and how
is it being used in orthopedics today?
Dr. Chad Greer:
So regenerative medicine is a broad term that's being used
really with multiple treatments that are not typically considered
mainstream or historically used.
And some of those can include things like PRP or A two M,
and stem cell interventions.
and these things that are more, cutting-edge and more, prone to, dealing
with their body trying to heal itself.
Whereas historically we've tried to combat.
disease with, anti-inflammatories and medications, as well
as other interventions.
Caitlin Whyte (Host): And what types of injuries or conditions are most likely
to benefit from regenerative treatments like PRP or even stem cell therapy?
Dr. Chad Greer:
So there's really a broad range of things we can treat, non-operatively with those
interventions, including tendinopathies as well as early degenerative change.
anything from, you know, classic tennis elbow.
That is given somebody chartable and not able to get better with your
historic treatments, as well as early degenerative change of joints, which
we're seeing obviously, as people age.
Caitlin Whyte (Host): So how do these therapies actually work inside the body
to promote that healing or reduce pain?
Dr. Chad Greer:
So the idea, really depending on the treatment, of the
condition that you're looking at.
So, for instance, we will use tendinopathy as an example.
So someone who has a Breakdown of their, tendon, in an abnormal way that
continues to cause chronic inflammation and pain for, say, someone who has
tenness elbow, which is a, a common, condition that tendon has, entered
into a state where it's unable to.
Be recognized, your body, that it needs repair, but it's continued to have some
chronic inflammation that causes pain.
And so the idea behind PRP in this case would be to take the healing properties of
your own blood, but concentrate them, in a way that, if we apply them to that area,
get your body to recognize that it needs to repair that area or otherwise it's
entered into this indolent state where it, your body just doesn't recognize it.
Caitlin Whyte (Host): Wow.
Can you walk us through what a typical treatment process looks like for a
patient starting with that evaluation?
Through that recovery?
Dr. Chad Greer:
Sure.
I mean, I think the evaluation, of course is the most important part
because no, condition is the same and no two people are the same.
And so I think, having someone evaluate you.
See exactly what your condition is And what treatments you've had And
you've failed and not failed is probably the most important first step.
And then seeing what condition it is that will kind of dictate what
you may be most responsive to.
And so let's say a PRP, for instance, might be something that we think that
you'd be responsive to the process for that would be, once we've established
the diagnosis And the treatment plan for PRP, we would bring you in.
PRP is the process of drawing your blood, spinning it in a centrifuge where it
concentrates the areas of the blood.
In this case, the platelets And the growth factors to a concentration that's
higher than circulating in your blood.
And we then take that and, in a case of a tendon, we inject that
into the area to try to stimulate your body to repair that area.
Caitlin Whyte (Host): Now there is so much buzz around regenerative medicine.
What does the current evidence say about effectiveness and long-term outcomes?
Dr. Chad Greer:
Well, sure.
That's certainly the biggest question, right?
Is that because there's, over the years been lots of different devices
that concentrate things at different levels and no two, Pharmaceutical
companies produce the same type of.
engineering that allows us to kind of have a, good standard to go by.
we've then had to, not have as much evidence as we would've
liked to have had, thus far.
but there's enough evidence, out there that suggests, particularly with
tendinopathy that PRP, is likely to give some improvement, if not give
significant improvement, particularly.
The most, that's been studied has been, lateral epicondylitis,
commonly known as tennis elbow, as well as, mild to moderate DEET
degenerative change of the joint.
So both of those conditions actually have, You know, decent evidence to
suggest it's a good tool for us to try.
we do extrapolate that to other areas of the body and other tendinopathies,
because we don't have the, studies to back up necessarily other areas of the body.
But I certainly have seen success.
but the ability to, have a study to quote in other areas of the body
can be more difficult 'cause the research just isn't called up yet.
Caitlin Whyte (Host): Mm-hmm.
Well, how do you help patient's decide whether regenerative medicine
is the right option compared to more traditional treatments or surgery?
Dr. Chad Greer:
I think that's exactly what, we try to do is we evaluate the patient, from start to
finish, meaning what, has been tried so far, what has worked, what's their past
medical history, how does that factor in?
then you'd have to see exactly what condition you're treating.
'cause some conditions are gonna be more responsive than other's.
and what's the pathology there?
And so I think.
whenever you're looking at these things, you really want somebody who's looking at
you as a whole person, both considering you know your other medical problems,
other medical conditions, medications that you're on, what experiences you've had
with treatments previously, what you're responsive to, And then putting that
all together to give you the treatment plan for whether the regenerative,
treatments may be beneficial to you.
Caitlin Whyte (Host): And looking ahead, doctor, what?
advances or innovations in regenerative orthopedics are you most excited about?
Dr. Chad Greer:
I think mostly it's just more research in the areas that give us more concrete
evidence that go to insurance companies and say, Hey, we need this approved And
for you to pay for these, procedures.
I think the evidence is getting there, particularly for certain conditions,
but I think that's probably been the biggest holdback over the years is that,
this has all typically been a cash pay, because insurances are not covering this.
I will say the exception has been Tricare, has, temporarily covered, lateral
epicondylitis, which is tennis elbow, as well as, mild knee to generate change.
So I think at least we've had some progress there, but I'd like to see more
progress with more coverage so that we can get these treatments to more people.
Caitlin Whyte (Host): Absolutely.
That was Dr.
Chad Greer.
To learn more about Wake Orthopedic Services, please visit wake ortho.com
if you enjoyed this podcast, please share it on your social channels and
check out the entire podcast library.
For topics of interest to you,
. I'm your host, Kaitlyn White, with WakeMed Voices brought to you by WakeMed Health
and Hospitals in Raleigh, North Carolina.
Thanks for listening.